ArticleJournal of patient experience2026
Implementing Early Depression Screening as Routine Practice in Pharmacy Settings.
Article in Journal of patient experience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study examined the feasibility and impact of implementing routine depression screening in pharmacy settings through a 4-phase approach. A systematic literature review identified evidence supporting pharmacist-led screenings as effective and acceptable, with studies reporting improved detection rates and positive patient outcomes. Legislative analysis revealed strong international frameworks, particularly in the United States and United Kingdom, emphasizing pharmacists' role in mental health care. A situational analysis in Bulgaria highlighted a significant unmet need, with high prevalence of depressive symptoms among chronically ill patients and limited access to mental health specialists. These findings underscore the potential of community pharmacies to bridge care gaps. Based on the evidence, key recommendations include developing pharmacist training programs, advocating for supportive legislation and funding, launching public awareness campaigns to reduce stigma, and establishing collaborative referral networks with other healthcare providers. Implementing these measures can facilitate early detection, timely intervention, and improved public health outcomes by leveraging the accessibility and expertise of pharmacists in mental healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.